Yifeng Pharmacy Chain Co., Ltd. (603939.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 22.69

From 52W high−9.80%

Volume6.34M

Market capCNY 28.67B

P/E (TTM)17.1x

P/S (TTM)1.1x

Div yield1.76%

Key dataSep 18, 2026

Open

CNY 22.69

From 52W high

−9.80%

Volume

6.34M

Market cap

CNY 28.67B

ValuationView details →

P/E (Fwd)

14.4x

EV/EBITDA

9.1x

P/E (TTM)

17.1x

RSI (14)

48.7

MomentumView details →

1D Return

−1.17%

YTD Return

+4.88%

ValuationView details →

P/E (Fwd)

14.4x

P/E (TTM)

17.1x

EV/EBITDA

9.1x

EV/Sales

1.1x

P/S (TTM)

1.1x

P/B (TTM)

2.5x

ProfitabilityView details →

Gross Margin

39.46%

Net Margin

7.05%

EBITDA Margin

12.05%

ROE (TTM)

14.25%

ROA (TTM)

6.44%

Asset Turnover

0.90x

GrowthView details →

Revenue YoY

+1.70%

EPS YoY

+9.81%

FCF YoY

−26.09%

Revenue CAGR 3Y

+7.10%

EPS CAGR 3Y

+3.08%

EBITDA YoY

—

MomentumView details →

1D Return

−1.17%

YTD Return

+4.88%

1Y Return

−9.67%

RSI (14)

48.7

vs 50D SMA

+0.09%

vs 200D SMA

+0.86%

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

1.54x

Quick Ratio

1.14x

Div Yield

1.76%

Div Rate

CNY 0.40

Div Growth 1Y

−6.67%

EarningsView details →

EPS (Actual)

CNY 0.38

EPS Surprise

−5.00%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.33

Avg Surprise (4Q)

−5.00%

Rev Surprise

−0.95%

Financials snapshotView financials →

Revenue (TTM)

24.51B

Net Income (TTM)

1.73B

Op. CF (TTM)

3.30B

Next earningsOct 29, 2026 →

Latest newsMore news →

Yifeng Pharmacy announced a 2026 half-year cash dividend of RMB 0.30 per share to all shareholders, during which conversion of the Yifeng Convertible Bond will be suspended from September 22, 2026 until the record date.5d ago

Yifeng Pharmacy announced that as of August 31, 2026, it had repurchased 3.9773 million shares for 89.992 million yuan under its ongoing buyback program.20d ago

Similar companies

同仁堂600085.SH BeOne Medicines Ltd.ONC 康美药业600518.SH Alibaba Health Information Technology Limited00241.HK 西藏药业600211.SH Cellid, Co., Ltd.299660.KQ Find similar companies →

Latest newsMore news →

Yifeng Pharmacy announced a 2026 half-year cash dividend of RMB 0.30 per share to all shareholders, during which conversion of the Yifeng Convertible Bond will be suspended from September 22, 2026 until the record date.5d ago Yifeng Pharmacy announced that as of August 31, 2026, it had repurchased 3.9773 million shares for 89.992 million yuan under its ongoing buyback program.20d ago Yifeng Pharmacy proposed a cash dividend of 0.30 yuan per share (tax included).25d ago